Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Neoplasms

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

NCT00331682

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers

NCT00183846

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +21 more
Locations: U.S.C./Norris Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas

NCT00002955

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery

NCT00305877

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer

NCT00091026

Conditions: Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors

NCT00841191

Conditions: Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +30 more
Locations: Philadelphia, Pennsylvania, United States

Houston, Texas, United States

Brussels, Belgium

Wilrijk, Belgium

View Trial Details

Completed

Study of CellCept for Advanced Pancreatic Cancer

NCT00997958

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Columbia University Medical Center New York, United States

View Trial Details

Completed

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

NCT01020006

Conditions: Digestive System Diseases, Digestive System Neoplasms, Ductal Adrenocarcinoma, +12 more
Locations: TGen Clinical Reserch Services at Scottsdale Healthcare Scottsdale, Arizona, United States

Pacific Cancer Medical Center Anaheim, California, United States

Space Coast Medical Associates Titusville, Florida, United States

Investigative Clinical Research of Indiana Indianapolis, Indiana, United States

View all 17 locations

View Trial Details

Completed

Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS

NCT01479803

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Hôpital L'Archet 2, CHU Nice, BP 3079 Nice, France

View Trial Details

Completed

Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer

NCT02118077

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Not specified

View Trial Details